Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Rockwell Medical (RMTI) Cost of Revenue (2016 - 2026)

Rockwell Medical filings provide 16 years of Cost of Revenue readings, the most recent being -$40.7 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 32.35% to -$40.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$23.8 million, a 39.52% increase, with the full-year FY2025 number at $2.4 million, down 14.37% from a year prior.
  • Cost of Revenue hit -$40.7 million in Q4 2025 for Rockwell Medical, down from $531000.0 in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $21.6 million in Q3 2023 to a low of -$60.2 million in Q4 2024.
  • Median Cost of Revenue over the past 5 years was $656000.0 (2024), compared with a mean of -$3.1 million.
  • Biggest five-year swings in Cost of Revenue: surged 3651.43% in 2023 and later tumbled 413.28% in 2024.
  • Rockwell Medical's Cost of Revenue stood at -$41.1 million in 2021, then fell by 20.97% to -$49.7 million in 2022, then skyrocketed by 138.7% to $19.2 million in 2023, then tumbled by 413.28% to -$60.2 million in 2024, then soared by 32.35% to -$40.7 million in 2025.
  • The last three reported values for Cost of Revenue were -$40.7 million (Q4 2025), $531000.0 (Q3 2025), and $572000.0 (Q2 2025) per Business Quant data.